Domov › Gravesova bolezen › Florida
Klinične študije za Gravesova bolezen v Florida
8 študij za Gravesova bolezen išče udeležence na lokacijah v Florida.
Mesta v Florida
Uradno besedilo študije (angleško)
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- DM Clinical Research, Doral
- Floridian Clinical Research - Clinitiative, Miami
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07722546Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-052, Doral
- Site-066, Fort Myers
- Site-019, Hialeah
- in še 4
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07661056NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1101, Hollywood
- Site # 1112, Miami
- Site # 1109, Wesley Chapel
Vključevanje udeležencevFaza 1
Starost 18–65 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07305818A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Northeast Florida Endocrine & Diabetes Associates (NEFEDA) - Orange Park Location, Fleming Island
- The Center for Diabetes and Endocrine Care, Fort Lauderdale
- University of Florida Jacksonville College of Medicine, Jacksonville
- in še 2
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07570316Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 109, Miami Lakes
- Site 115, Palm Harbor
- Site 123, Sarasota
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1024, Doral
- Site Number - 1008, Hialeah
- Site Number - 1000, Miami
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07018323A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1029, Clearwater
- Site Number - 1055, Jacksonville
- Site Number - 1056, Jacksonville
- in še 4
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
- Site-100, Miami
Vključevanje udeležencevFaza 1
Starost 18–65 · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT06980649Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.